VivoSeq
Dermatology

Burn Wounds

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Burn Wounds is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

25/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Completed2 · 25%
Unknown status2 · 25%
Recruiting2 · 25%
Withdrawn1 · 13%
Terminated1 · 13%

Clinical Trials

Trial Activity

8 trials

Microsurfaced Grafts in Deep Burn Wounds
Recruiting·CCellTherX·Phase 4·NCT04589442·20 enrolled
SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma
Recruiting·—·Phase 1/2·NCT02350205·52 enrolled
Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds
Completed·BBirken AG·Phase 3·NCT01657292·61 enrolled
Study to Evaluate the Use of Tilapia Skin (Oreochromis Niloticus), in the Treatment of Burn Wounds
Completed·NNucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara·Phase 2·NCT03592498·63 enrolled
Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks
Terminated·TThe University of Texas Medical Branch, Galveston·Phase 2/3·NCT00675922·98 enrolled
Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds
Withdrawn·MMetroHealth Medical Center·Phase 1·NCT00479193
Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)
Unknown status·AA.A. Partners, LLC·Phase 1/2·NCT03113747·20 enrolled
MSCs for the Treatment of Burn Wounds
Unknown status·IInstituto Venezolano de Investigaciones Cientificas·Phase 1/2·NCT06103409·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)